Managing Blood Clots in Patients with Blood Cancers at Home
Author Information
Author(s): Tendas Andrea, Cupelli Luca, Scaramucci Laura, Palombi Massimiliano, Trawinska Malgorzata, Monika Giovannini, Marco Brunetti, Gregorio Antonio, Cartoni Claudio, Bondanini Francesco, de Fabritiis Paolo, Niscola Pasquale
Primary Institution: Hematology Unit, S. Eugenio Hospital, Rome, Italy
Hypothesis
Can anticoagulant and anti-thrombotic treatments be safely administered to patients with hematological malignancies in a home care setting?
Conclusion
The use of anticoagulant and anti-platelet drugs in home care for patients with hematological malignancies rarely leads to significant complications.
Supporting Evidence
- 20% of patients were treated with anticoagulant or anti-platelet drugs.
- Adverse events were observed in 11.5% of treated patients.
- None of the patients with bleeding complications had thrombocytopenia.
Takeaway
Doctors can give certain blood-thinning medicines to patients with blood cancers at home, and it usually doesn't cause serious problems.
Methodology
A prospective evaluation of anticoagulant and anti-thrombotic agents was conducted on patients followed at home during the first semester of 2010.
Limitations
The study was limited to a single-center and may not represent broader populations.
Participant Demographics
{"total_patients":129,"age_range":"20-98","gender_distribution":{"male":57,"female":72},"diagnoses":{"MDS/cMPD":53,"acute_leukemia":11,"lymphoma":18,"plasma_cell_dyscrasia":12,"cancer_unrelated_anemia":21,"other":14}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website